Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,940 | 1,025 | 96.2% |
| Consulting Fee | $450.00 | 3 | 2.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $255.31 | 15 | 1.4% |
| Education | $7.12 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,045 | 165 | $0 (2024) |
| Biogen, Inc. | $1,466 | 54 | $0 (2024) |
| Novocure Inc. | $1,136 | 21 | $0 (2024) |
| UCB, Inc. | $1,008 | 51 | $0 (2024) |
| Amgen Inc. | $991.65 | 47 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $794.60 | 69 | $0 (2022) |
| ACADIA Pharmaceuticals Inc | $730.29 | 39 | $0 (2024) |
| Celgene Corporation | $723.63 | 47 | $0 (2024) |
| Grifols USA, LLC | $720.64 | 41 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $710.69 | 55 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,333 | 171 | ABBVIE INC. ($586.88) |
| 2023 | $2,766 | 141 | ABBVIE INC. ($510.19) |
| 2022 | $2,186 | 139 | ABBVIE INC. ($485.71) |
| 2021 | $2,835 | 161 | UCB, Inc. ($350.62) |
| 2020 | $2,038 | 126 | Teva Pharmaceuticals USA, Inc. ($265.04) |
| 2019 | $2,097 | 112 | Biogen, Inc. ($339.60) |
| 2018 | $1,866 | 100 | Amgen Inc. ($194.89) |
| 2017 | $1,532 | 94 | Teva Pharmaceuticals USA, Inc. ($204.66) |
All Payment Transactions
1,044 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $83.95 | General |
| Category: Oncology | ||||||
| 12/16/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/13/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.48 | General |
| Category: Neuroscience | ||||||
| 12/10/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: PAIN | ||||||
| 12/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Neuropsychiatry | ||||||
| 12/05/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $28.69 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/02/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Neurology | ||||||
| 12/02/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/26/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/26/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Rare Disease | ||||||
| 11/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $10.10 | General |
| Category: Neuropsychiatry | ||||||
| 11/15/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: EPILEPSY | ||||||
| 11/14/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $28.57 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/12/2024 | Genentech, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $50.07 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $31.69 | General |
| Category: Neuropsychiatry | ||||||
| 11/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $7.52 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | Cash or cash equivalent | $123.91 | General |
| Category: Neuroscience | ||||||
| 11/08/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $19.14 | General |
| Category: Neuroscience | ||||||
| 11/06/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $9.90 | General |
| Category: Neuroscience | ||||||
| 11/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.59 | General |
| Category: PAIN | ||||||
| 11/02/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.53 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Neuroscience | ||||||
| 10/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 601 | 1,490 | $240,125 | $69,162 |
| 2022 | 10 | 490 | 559 | $150,657 | $50,380 |
| 2021 | 10 | 454 | 533 | $139,487 | $47,411 |
| 2020 | 13 | 610 | 710 | $172,898 | $54,340 |
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 193 | 239 | $56,165 | $20,046 | 35.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 90 | 90 | $41,400 | $13,988 | 33.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 88 | 107 | $35,096 | $12,769 | 36.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 35 | 35 | $12,390 | $3,970 | 32.0% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 18 | 18 | $18,666 | $3,704 | 19.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 59 | $9,263 | $3,023 | 32.6% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 11 | 11 | $8,503 | $3,000 | 35.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 20 | 33 | $9,240 | $2,393 | 25.9% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 24 | 39 | $5,577 | $1,767 | 31.7% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 13 | 13 | $8,034 | $1,700 | 21.2% |
| 70553 | Mri scan of brain before and after contrast | Office | 2023 | 11 | 11 | $27,246 | $1,429 | 5.2% |
| 95955 | Measurement of brain wave activity (eeg) outside the brain during surgery | Facility | 2023 | 30 | 30 | $7,740 | $1,178 | 15.2% |
| A9585 | Injection, gadobutrol, 0.1 ml | Office | 2023 | 11 | 805 | $805.00 | $195.33 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 142 | 181 | $41,699 | $15,809 | 37.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 61 | 61 | $27,540 | $9,617 | 34.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 108 | 115 | $17,527 | $6,549 | 37.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 48 | 48 | $16,692 | $5,599 | 33.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 29 | 33 | $10,608 | $4,052 | 38.2% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 11 | 11 | $8,503 | $2,825 | 33.2% |
| 95955 | Measurement of brain wave activity (eeg) outside the brain during surgery | Facility | 2022 | 47 | 50 | $12,852 | $2,033 | 15.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 19 | 25 | $6,630 | $1,796 | 27.1% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2022 | 14 | 24 | $3,432 | $1,058 | 30.8% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 11 | 11 | $5,174 | $1,041 | 20.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 90 | 117 | $25,272 | $10,623 | 42.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 147 | 167 | $23,547 | $10,305 | 43.8% |
About Dr. Jon Olson, MD
Dr. Jon Olson, MD is a Neurology healthcare provider based in Baton Rouge, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1619966819.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jon Olson, MD has received a total of $18,652 in payments from pharmaceutical and medical device companies, with $3,333 received in 2024. These payments were reported across 1,044 transactions from 65 companies. The most common payment nature is "Food and Beverage" ($17,940).
As a Medicare-enrolled provider, Olson has provided services to 2,155 Medicare beneficiaries, totaling 3,292 services with total Medicare billing of $221,293. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Baton Rouge, LA
- Active Since 10/19/2005
- Last Updated 03/28/2008
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1619966819
Products in Payments
- UBRELVY (Drug) $1,149
- TYSABRI (Biological) $1,025
- Optune (Device) $926.11
- Aimovig (Biological) $836.49
- ZEPOSIA (Drug) $823.67
- NURTEC ODT (Drug) $814.47
- NUPLAZID (Drug) $730.29
- Gamunex-C (Biological) $720.64
- Vimpat (Drug) $580.39
- BOTOX (Biological) $525.46
- Hizentra (Biological) $418.08
- AJOVY (Biological) $415.28
- Briviact (Drug) $405.43
- INGREZZA (Drug) $392.85
- INBRIJA (Drug) $337.09
- TROKENDI XR (Drug) $324.11
- QULIPTA (Drug) $294.58
- COPAXONE (Drug) $273.97
- AIMOVIG (Biological) $268.89
- APTIOM (Drug) $257.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Baton Rouge
Kevin Callerame, Md, MD
Neurology — Payments: $441,181
William Gladney, Md, MD
Neurology — Payments: $69,765
Joseph Acosta, Md, MD
Neurology — Payments: $50,436
Benjamin Kidder, Md, MD
Neurology — Payments: $47,410
Dr. Dariusz Gawronski, Md, MD
Neurology — Payments: $7,079
Dr. Ashok Reddy Polu, M.d, M.D
Neurology — Payments: $2,433